IXHL Short Volume

Incannex Healthcare Limited (IXHL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $43.6M, listed on NASDAQ, employing roughly 12 people, carrying a beta of 2.83 to the broader market. Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. Led by Joel Bradley Latham, public since 2022-03-02.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-09-22
Short Volume
13.0K
Total Volume
27.0K
Short %
48.36%
30-Day Avg Short %
33.11%

Showing 30 days of FINRA short volume data for Incannex Healthcare Limited.

Learn how short volume is reported and how to read the data →

Frequently asked IXHL short volume questions

What is the daily IXHL short volume?
As of Sep 22, 2026, Incannex Healthcare Limited (IXHL) short volume is 13.0K shares against 27.0K total reported volume, or 48.36% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is IXHL short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does IXHL short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.